Ornstein, Moshe C.
Rini, Brian I.
Article History
First Online: 11 December 2018
Competing interests
: M.C.O. has received fees as a consultant of Bristol-Myers Squibb, Exelixis, Eisai and Pfizer. B.I.R. has received fees as a consultant of Bristol-Myers Squibb, Merck and Pfizer.